The role for pharma companies in addressing global public health challenges
Collaboration across public, private and civil society is essential if SDG goals on AIDS, TB and malaria are to be met.
Read more
Perspectives
Thought leadership and market insight on M&A, healthcare, restructuring and capital markets.
Collaboration across public, private and civil society is essential if SDG goals on AIDS, TB and malaria are to be met.
Read moreHealthcare services and technology is among the fastest-growing profit pools — with substantial headroom for platform players.
Read moreInternal M&A capability is a major driver of deal success — yet skill gaps and capacity issues remain common.
Read moreCulture and human capital are often ignored in M&A — high performers capture far more synergies than the business case.
Read moreStabilise operations while implementing longer-term financial and operational transformation.
Read moreLarge deals can destroy value — yet half created excess shareholder returns after two years when strategy and execution align.
Read morePE-backed companies outperformed public peers when recovering from distress across a multi-year study.
Read moreGlobal M&A has risen since 2013, driven by excess capital seeking deployment opportunities.
Read morePairing capital with commercially viable infrastructure projects for governments, developers and investors.
Read more